Treatment of Arsenic Toxicity during APML Treatment in a Pediatric Patient
Received Date: Nov 02, 2021 / Accepted Date: Nov 16, 2021 / Published Date: Nov 23, 2021
Abstract
A 17-year-old healthy female was presented with altered mentation after a fall. The workup revealed a new onset of APML. Chemotherapy was initiated. She developed MODS requiring ECMO and CVVHDF. Two days after discontinuation of support, the patient developed acute worsening mentation, emesis, diarrhea, tachycardia, fever, creatinine of 9.58 mg/dL, and prolonged QTc-582, indicating arsenic poisoning from chemotherapy.
Keywords: Arsenic Toxicity; Emesis; Mentation; Hemodialysis
Citation: Patel R, Kishk O, Savva DA, Holloway A (2021) Treatment of Arsenic Toxicity during APML Treatment in a Pediatric Patient. Toxicol Open Access 7:164.
Copyright: © 2021 Patel R, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Open Access Journals
Article Usage
- Total views: 1909
- [From(publication date): 0-2021 - Dec 19, 2024]
- Breakdown by view type
- HTML page views: 1551
- PDF downloads: 358
